Table 1.
Patienta | Karyotype | Phenotype | Gene disruption | |
---|---|---|---|---|
1 | 46,X,t(X;7)(q13;p15) | ID, primary amenorrhea | Xq13.1 | EDA |
7p21.1 | – | |||
2 | 46,X,t(X;3)(q13.3;q11.2) | ID, primary amenorrhea | Xq13.3 | NEXMIF |
3q11.2 | – | |||
3 | 46,X,t(X;9)(q13.3;cen) | Primary amenorrhea | Xq13.3 | ZDHHC15 |
9cen | – | |||
4 | 46,X,t(X;1)(q13;p34) | Primary amenorrhea | Xq21.1 | – |
1p34.3 | CLSPN | |||
5 | 46,X,t(X;11)(q21.1;q14.2) | Secondary amenorrhea | Xq21.1 | APOOL |
11q14.2 | – | |||
6 | 46,X,t(X;2)(q21.33;q12.1) | Primary amenorrhea | Xq21.33 | – |
2q12.1 | – |
ID intellectual disability
aPatients 2, 3, 5, and 6 clinically described by Moyses-Oliveira et al. 2019 [30]